UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000040254
Receipt No. R000045749
Scientific Title Readmission and school/work engagement after discharge from psychiatric hospitals among long-stay patients with severe mental illness: A systematic review of the literature
Date of disclosure of the study information 2020/05/01
Last modified on 2020/04/27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A systematic review of return to community for long-term psychiatric inpatients
Acronym A systematic review of return to community for long-term psychiatric inpatients
Scientific Title Readmission and school/work engagement after discharge from psychiatric hospitals among long-stay patients with severe mental illness: A systematic review of the literature
Scientific Title:Acronym Readmission and school/work engagement after discharge from psychiatric hospitals among long-stay patients with severe mental illness: A systematic review of the literature
Region
Japan

Condition
Condition severe mental illness
Classification by specialty
Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this systematic review is to examine readmission rates, readmission days, employment rates, and school enrollment rates after discharge focusing on psychiatric patients hospitalized for more than one year with a severe mental illness.

P:Adults with SMI
E:long-term (i.e. 1 year or longer) inpatient care in psychiatric hospitals or psychiatric wards in general hospitals
O:readmission, number of days in hospitals, number of days in community, and school/work engagement or other social participation after discharge
S:observational study, cohort study, and randomized controlled trial
Basic objectives2 Others
Basic objectives -Others Same as above
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Readmission rate defined as the percentage of patients hospitalised during the first year after discharge and days of readmission defined as the number of days of hospitalization in the year after discharge
Key secondary outcomes 1)Readmission rates and readmission days within the follow-up period set by each study, other than those described in the previous section
2)Percentage of those discharged from hospitals who were employed enrolled in school or participated in social activities such as volunteering within the follow-up period set by each study
3)Level of severity in psychiatric symptoms measured by rating scales (e.g. PANSS, BPRS), level of social functioning measured by rating scales (e.g. GAF), quality of life, and well-being measured by self-report questionnaires (e.g.WHO-QOL26, SF36) at the end of the follow-up period set by each study

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
64 years-old >=
Gender Male and Female
Key inclusion criteria adults aged between 18 and 64 with diagnosis of severe mental illness who have been hospitalized 1 year or longer and were discharged from psychiatric inpatient care
Key exclusion criteria Single diagnosis of mental disorders due to known physiological conditions (ICD-10 F0); psychoactive substance use (F1); anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders (F4); eating disorders (F50); adult personality and behavior (F6); intellectual disabilities (F7); or pervasive and specific developmental disorders (F8).
Target sample size

Research contact person
Name of lead principal investigator
1st name Sayaka
Middle name
Last name Sato
Organization National Institute of Mental Health, NCNP
Division name Department of Community Mental Health & Law
Zip code 1878553
Address 4-1-1 Ogawa-higashi Kodaira Tokyo Japan
TEL 0423462039
Email sayakas@ncnp.go.jp

Public contact
Name of contact person
1st name Sayaka
Middle name
Last name Sato
Organization National Institute of Mental Health, NCNP
Division name Department of Community Mental Health & Law
Zip code 187-8553
Address 4-1-1 Ogawa-higashi Kodaira Tokyo Japan
TEL 0423462039
Homepage URL
Email sayakas@ncnp.go.jp

Sponsor
Institute National Institute of Mental Health, NCNP
Institute
Department

Funding Source
Organization National Institute of Mental Health, NCNP
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization National Institute of Mental Health, NCNP
Address 4-1-1 Ogawa-higashi Kodaira Tokyo Japan
Tel 0423462039
Email sayakas@ncnp.go.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 05 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2019 Year 10 Month 01 Day
Date of IRB
Anticipated trial start date
2019 Year 10 Month 31 Day
Last follow-up date
2020 Year 10 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information We will report a narrative synthesis. Specifically, the country, year of publication, readmission rate, and the number of days of readmission for each article are summarized in a table. We will use meta-analytic techniques, if appropriate.

If there are ten or more studies in the systematic review, we will examine publication bias by visual inspection of funnel plots.

Management information
Registered date
2020 Year 04 Month 27 Day
Last modified on
2020 Year 04 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045749

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.